Medical and Pharmaceutical Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug The authorization could help facilitate significant revenue growth Rowan DunneApril 12, 2026
Health & Wellness Mayo Clinic study shows robotic tech improves early lung cancer diagnosis The system also integrates endobronchial ultrasound to examine nearby lymph nodes Joseph MortonApril 8, 2026
Medical and Pharmaceutical BriaCell transfers cancer immunotherapy asset to BriaPro in USD$1.18 million deal BriaCell originally licensed the technology from the University of Maryland Joseph MortonApril 2, 2026
Medical and Pharmaceutical Guardant Health gets oncology innovation accolade at Healthcare Asia Medtech Awards 2026 The company was recognized for its multi-cancer detection test Rowan DunneMarch 31, 2026
AI and Autonomy Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI The companies plan to build proof-of-concept models that predict how patients will respond to treatment Joseph MortonMarch 27, 2026
Medical and Pharmaceutical Enliven Therapeutics stock climbs on upgrades, sector validation from Merck acquisition Enliven Therapeutics is a clinical-stage biotech company focused on developing targeted cancer drugs Joseph MortonMarch 26, 2026
Medical and Pharmaceutical Eli Lilly funds Indigenous lung health education initiative in North America 'Healthy Workforce, Productive Community' will extend for 3 years Rowan DunneMarch 25, 2026
Medical and Pharmaceutical bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction Shares rose by 73% during the session with no immediate catalyst Rowan DunneMarch 23, 2026
Medical and Pharmaceutical Guardant Health launches multi-cancer blood test in Asia through Manulife partnership Cancer remains a leading cause of death across Asia, driving demand for early screening tools Joseph MortonMarch 18, 2026
Medical and Pharmaceutical Monash University’s medical engineering institute progresses silicosis breath test Its MedTech Commercialisation Advancement Program has been expediting the tool's development Rowan DunneMarch 9, 2026